Methicillin-resistant Staphylococcus aureus (MRSA) is a type of bacteria that is resistant to certain antibiotics. These antibiotics include methicillin and other more common antibiotics such as oxacillin, penicillin and amoxicillin. Staph infections, including MRSA, occur most frequently among persons in hospitals and healthcare facilities (such as nursing homes and dialysis centers) who have weakened immune systems.
MRSA infections that occur in otherwise healthy people who have not been recently (within the past year) hospitalized or had a medical procedure (such as dialysis, surgery, catheters) are known as community-associated (CA)-MRSA infections. These infections are usually skin infections, such as abscesses, boils, and other pus-filled lesions.
Microbiologists at the Health Protection Agency suspect that the superbug which has already caused 12 deaths at Stoke Mandeville Hospital, in Buckinghamshire, may be the same strain that has spread in many American hospitals since 2001, and killed more than 100 patients in Quebec, Canada, last year.
There have been some 300 cases of Clostridium difficile in 18 months at Stoke Mandeville Hospital, in Aylesbury, Bucks, a national centre for spinal injury, and it is thought that the infection was an "actual or probable" factor in 12 deaths in that time.
A major cause of hospital-acquired infections can persist for days and even weeks on environmental surfaces found in healthcare settings, including bed linens, computer keyboard covers and acrylic fingernails
The University Hospitals of Leicester NHS Trust, in the continuing row over whether bibles and other religious literature left at the side of patients beds constitute a risk of MRSA infections, now says it will give the ward bibles to patients to take home.
University Hospitals of Leicester NHS Trust are on the verge of a very embarrassing public relations disaster after the trust's chaplain stalled a request from Gideons International to be allowed to replace patients' bedside Bibles.
The UK's Health Protection Agency (HPA) is to begin a study reviewing bloodstream infections in children caused by methicillin-resistant Staphylococcus aureus (MRSA).
Insense Ltd, a UK biotechnology company, announced successful clinical trial results for "Oxyzyme", a new product for advanced treatment of chronic wounds.
Ms Hewitt has promised a "much stronger" legal framework in the National Health Service (NHS) to help hospitals reduce the rate of antibiotic-resistant MRSA and other hospital acquired infections.
Inspectors have found that in a third of NHS hospitals, clinical waste was not being stored safely out of patients' reach, and hospitals are putting patients' lives at risk by not getting rid of clinical waste properly.
Vanderbilt University Medical Center infectious diseases researchers are launching a trial for a new vaccine against Staphylococcus aureus. The vaccine, if proven effective, could help curb the growing threat of methicillin-resistant Staphylococcus aureus (MRSA), an emerging organism rapidly spreading through close personal contact.
As science gets wiser, so do the bugs. The rates of drug-resistant bacteria infecting patients in the community and in the hospital have been increasing steadily in recent years, according to two new studies in the June 15 issue of Clinical Infectious Diseases.
The discovery of a 'molecular switch' could lead to new ways of treating infections such as MRSA, and inflammatory diseases like arthritis.
Hospital cleaners, nurses and health workers today attacked claims by Michael Howard that the Tories could be trusted to Clean up our hospitals as outrageous.
A new study has shown that some nasty bacteria can survive and grow for at least 24 hours on computer keyboards and electronic recordkeeping in hospitals and other health care settings and may be spreading more than just information.
Two teams of experts are saying that a drug-resistant "superbug" previously only found in hospitals is becoming more common in the community and must be aggressively treated. They say that staphylococcus aureus, or staph, infections that are resistant to methicillin and similar drugs can now be put into the category of flesh-eating bacteria and doctors need to be aware of this and exchange antibiotics at the first sign of trouble.
Nylon strips, beads and hospital stitching thread covered in viruses could be an effective weapon against the hospital acquired superbug, methicillin-resistant Staphylococcus aureus, known as MRSA, according to research presented today (Tuesday, 05 April 2005) at the Society for General Microbiology's 156th Meeting at Heriot-Watt University, Edinburgh.
This "re-equipping and re-emergence" of a clone that caused a pandemic 40-50 years ago could mean that community acquired MRSA will spread faster and be more widespread than previously expected, warns an international team of researchers who have been studying the bacteria.
Political point-scoring over policies to control MRSA (meticillin-resistant Staphlococcus aureus) confuses cleanliness with the real failure in UK hospitals - poor hand hygiene and inadequate use of gloves, states an editorial in this week’s issue of The Lancet.
Researchers at the University of Minnesota have identified a newly emerging illness, named staphylococcal purpura fulminans. The disease begins as a respiratory tract infection, which then is infected by Staphylococcus aureus.
The British Veterinary Association (BVA) has warned that vets should take hospital-style precautions to avoid passing the MRSA "superbug" to animals, and should use sterile gloves, scrub suits and masks during operations to protect the animals.
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.